To build an ABA confidentiality privacy and information sharing decision system, first determine which entity, data, person, purpose, relationship, and governing source apply. Define role-based access, treatment and operations routes, authorization and representative authority, client communication preferences, minimum necessary where required, external requests, secure channels, safeguards, incident escalation, and evidence. Track every decision and change. HIPAA is one possible source; professional ethics, state law, education, employment, payer, minor, consumer-health, and contract rules may add or replace duties.

Define Ximena's confidentiality, privacy, and information-sharing decision system

Ximena builds the system around real decisions rather than a generic confidential flag. Viewing a record, discussing a case, sharing with a treating provider, answering a payer, replying to a school, using data for quality work, and publishing an example can have different purposes and routes. The information-use and disclosure register names the people, data, purpose, entity role, authority, route, scope, safeguard, decision, release or use, incident, validation, and review status.

Build the fields Ximena needs

The working record captures decision and request ID, organization and entity role, data owner and subject, data type and system, PHI or other classification, client and representative, communication and AAC, requester and verified identity, relationship, purpose, governing sources, required or permitted status, authority or authorization, role access, minimum-necessary analysis and exception, client restriction or confidential-communication request, recipient and destination, safeguard, fields and period, approval, release or denial, receipt, incident, mitigation, correction, recurrence, retention, validation, and closure. Structured fields keep people, requests, records, roles, dates, purposes, routes, and decisions searchable. Narrative preserves client preferences, professional reasoning, uncertainty, exceptions, and context while source requests, authorizations, releases, corrections, and audit history remain attributable.

Keep privacy and clinical authority separate

Ximena separates clinical authorship, client and representative choices, privacy decisions, payer requests, education and employment routes, security administration, reporting, and legal review. Software and coordinators can enforce access and route evidence. They cannot infer authority, declare a disclosure lawful, or rewrite clinical content.

Apply Ximena's workflow

Ximena publishes a decision tree and role matrix. Routine recurring actions can use approved protocols with current sources and audit logs. Nonroutine requests receive individual review. The system blocks release when identity, purpose, route, recipient, or scope remains unresolved.

Start with entity and data scope

An ABA organization may be a HIPAA covered entity, a business associate for one function, outside HIPAA for another activity, or subject to additional law. Ximena documents the actual role and data flow before applying a HIPAA label. A privacy safeguard remains useful even when a particular rule does not apply.

Control urgent action and changed facts

Ximena routes immediate danger, medical emergency, suspected abuse or neglect, privacy or security incident, and legally required action through current authorized paths. A changed role, relationship, purpose, recipient, data set, client preference, restriction, source, or system reopens affected gates. Interim action records authority, scope, start, expiry, communication, and reassessment.

Work through Ximena's fictional example

Ximena locks 28 information decisions. Twenty-one have entity and data scope, purpose, authority, access, client route, recipient, safeguard, release evidence, and follow-up. One assumes every record is PHI, one grants title-based access, two family requests lack authority, one export is overbroad, and two controls lack validation. Five repair. Two remain open. This synthetic example tests workflow and denominator logic. It supplies no clinical, privacy, security, payer, education, employment, consumer-health, licensing, contract, or legal conclusion for a real person or organization.

Calculate Ximena's measures honestly

Initial governance integrity is 21 of 28, or 75.0%. Twenty-six decisions validate, or 92.9%. People, records, requests, uses, disclosures, fields, incidents, and tests retain separate denominators.

Address the main confidentiality, privacy, and information-sharing decision system risk

A universal HIPAA label can create both over-disclosure and unnecessary barriers when the practice never maps its actual entity role, data, purpose, and authority.

Test Ximena's artifact against hard cases

Ximena tests internal use, treatment disclosure, payer request, school request, caregiver call, quality review, de-identified data, incident, and non-HIPAA consumer data. Each case records identity, data, purpose, authority, route, scope, safeguard, decision, recipient, evidence, validation, and next review.

Close with open requests and residual risk visible

Ximena confirms entity and data scope, client preferences, access, authority, route, limits, safeguards, release or use evidence, incident response, correction, validation, and residual uncertainty. The confidentiality, privacy, and information-sharing decision system remains draft until every named reviewer finishes. Open work retains an owner, age, affected people, interim safeguard, and next action.

Place Ximena's privacy work inside accountable ABA operations

Ximena uses the CASP Organizational Guidelines public overview for high-level business, clinical-operations, and risk-management context. The ABA Practice Guidelines Version 3.0 public summary concerns ABA behavioral health treatment for people diagnosed with autism. CASP licenses the details. This confidentiality, privacy, and information-sharing decision system is an editorial model, not a CASP privacy protocol.

Apply behavior-analyst confidentiality duties within scope

Ximena uses the current BACB Ethics Code, which applies to BCBA and BCaBA certificants and people who completed an application. It addresses confidentiality, disclosures, records, understandable communication, client involvement, consent and assent when applicable, and professional responsibility. BACB has no separate organization or corporation jurisdiction, so entity, workforce, and legal duties require separate sources.

Classify HIPAA status before applying HIPAA rules

Ximena uses HHS covered-entity guidance to distinguish health plans, clearinghouses, covered healthcare providers, and business associates. Professional status or possession of health information alone does not settle HIPAA scope. The practice maps electronic covered transactions, functions, relationships, data, and hybrid roles, then evaluates other privacy laws and contracts independently.

Use TPO and minimum necessary with precise boundaries

Ximena uses HHS TPO guidance for specified treatment, payment, and healthcare-operations routes and HHS minimum-necessary guidance for covered uses, disclosures, and requests where it applies. The treatment exception concerns provider disclosures and requests for treatment; it is not blanket workforce access or a universal exemption from other law.

Separate representative authority from care involvement

Ximena uses HHS personal-representative guidance, which says applicable law determines authority and scope, and separate family-involvement guidance for directly relevant disclosures under specified conditions. An involved caregiver is not automatically a representative, and receiving information does not authorize disclosure back.

Implement privacy requests across the real workflow

Ximena maps applicable requests to current 45 CFR 164.522. Under HIPAA, restriction requests and confidential-communication requests follow different rules; providers must accommodate reasonable confidential-communication requests, while restriction decisions and exceptions require their own analysis. State law, payer operations, safety, and agreed restrictions can add constraints.

Use incidental-disclosure guidance as a bounded rule

Ximena uses HHS incidental-use guidance, which allows certain limited secondary disclosures only when the underlying use or disclosure is permitted, reasonable safeguards exist, and minimum necessary is applied where required. It does not excuse an impermissible underlying disclosure, unnecessary exposure, or missing safeguards.

De-identify and support communication accurately

Ximena uses HHS de-identification guidance for Expert Determination and Safe Harbor and recognizes a very small residual identification risk. It uses the ASHA AAC Practice Portal, which says AAC users should always have tool or device access. A removed name, synthetic label, or communication partner does not establish de-identification or author the person's choice.

Related resources

Sources